Recursion Pharmaceuticals

Description

Recursion Pharmaceuticals is a next-gen biopharma company combining experimental biology and automation with artificial intelligence to discover potential drugs for genetic disease, inflammation, immunology, and infectious disease.

Founders:

Blake Borgeson

Dean Li

Company Size:

201-500

TechBuzz Articles:

Recursion's IPO Generates $502 Million, Mark Tullis, April 2021

Buzzworthy Mentions:

Recursion Announces Partnerships with Roche and Genentech, December 10, 2021

Recursion Pharmaceuticals Files for a $100 Million IPO, March 26th, 2021